OBIO® Life Sciences Critical Technologies & Commercialization Program (LSCTC)

Amount of Funding

Strengthening Technology Commercialization: Provides 2:1 cash matching for funding between $25,000 to $100,000.

Technology Adoption: Provides 2:1 matching funds up to $250,000.

De-Risking of Emerging Technologies & Venture Creation: This program has no set maximum amount of funding allocated to it.

Eligible Applicants

Strengthening Technology Commercialization: A private, health science SME based in Ontario.

Technology Adoption: A private, health science SME based in Ontario.

De-Risking of Emerging Technologies & Venture Creation:

• Be either an emerging venture with intellectual property (IP) developed in Ontario, or an early stage, private health science small or medium enterprise (SME) (fewer than 500 paid FTE) based in Ontario with a high potential for company creation with operations in Ontario.

Eligible Activities

Strengthening Technology Commercialization Projects:

• Demonstrate that the technology solves a critical problem and a market exists for the product/service;

• Owns or has license agreement(s) in place for intellectual property associated with the technology; and

• Demonstrate that the completed project advances the company toward a significant value creation event.

Technology Adoption Projects:

• Successfully complete an initial pilot/validation study with supporting data;

• Create a market-ready product/service, ready to commercialize at scale;

• Raise dilutive funding or generating annual recurring revenues; and

• Are ready to have technology evaluated by a healthcare organization.

De-Risking of Emerging Technologies & Venture Creation:

• Seeks support with IP management, company creation, technology de-risking.

Program Deadline

Speak with a member of our team to find the latest intake period info for this program.